Phibro Animal Health (PAHC) Interest & Investment Income (2012 - 2026)
Phibro Animal Health's (PAHC) quarterly Interest & Investment Income came in at $250000.0 in Q1 2026, down 16.11% year-on-year from $298000.0 in Q1 2025, and down 65.52% quarter-over-quarter from $725000.0 in Q4 2025.
Phibro Animal Health (PAHC) Interest & Investment Income (2012 - 2026) Analysis & Trends
Phibro Animal Health's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $250000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 16.11% year-over-year to $250000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 45.8% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 41.39% from the prior year.
- Interest & Investment Income fell to $250000.0 in Q1 2026 per PAHC's latest filing, from $725000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.3 million in Q2 2024 and bottomed at $250000.0 in Q1 2026.
- The 4-year median for Interest & Investment Income is $782000.0 (2024), against an average of $777727.3.
- Across the five-year window, Interest & Investment Income increased 3.98% in 2024 and slumped 72.15% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $1.1 million in 2023, then fell by 26.5% to $782000.0 in 2024, then retreated by 7.29% to $725000.0 in 2025, then slumped by 65.52% to $250000.0 in 2026.
- Per Business Quant, the three latest PAHC Interest & Investment Income figures stand at $250000.0 (Q1 2026), $725000.0 (Q4 2025), and $484000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 250,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250,000.00 |
| Dec 31, 2025 | 725,000.00 |
| Sep 30, 2025 | 484,000.00 |
| Jun 30, 2025 | 418,000.00 |
| Mar 31, 2025 | 298,000.00 |
| Dec 31, 2024 | 782,000.00 |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2015 | 92,000.00 |
| Mar 31, 2015 | 60,000.00 |
| Dec 31, 2014 | 35,000.00 |
| Sep 30, 2014 | 62,000.00 |
| Jun 30, 2014 | -59,000.00 |
| Mar 31, 2014 | 66,000.00 |
| Dec 31, 2013 | 68,000.00 |
| Sep 30, 2013 | 44,000.00 |
| Jun 30, 2013 | 34,000.00 |